BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 13746610)

  • 21. [Investigation of calcium metabolism of Yoshida sarcoma and ascitic hepatoma with the aid of Ca45].
    ARAKI M; YONEZAWA T; SUGA K
    Gan; 1954 Sep; 45(2-3):133-4. PubMed ID: 13220786
    [No Abstract]   [Full Text] [Related]  

  • 22. Chromatographic studies of purine metabolism. I. The effect of azaserine on purine biosynthesis in E. coli using various C14-labeled precursors.
    KELLY HJ; SKIPPER HE; TOMISEK AJ
    Arch Biochem Biophys; 1956 Oct; 64(2):437-55. PubMed ID: 13363451
    [No Abstract]   [Full Text] [Related]  

  • 23. [ANTINEOPLASTIC ACTIVITY OF GOSSYPOL IN EXPERIMENTAL TRANSPLANTED TUMORS].
    VERMEL EM; KRUGLIAK SA
    Vopr Onkol; 1963; 9():39-43. PubMed ID: 14148612
    [No Abstract]   [Full Text] [Related]  

  • 24. THE INTERCONVERSION OF PURINES BY TUMORS AND THE ACTION OF ANTI-PURINES.
    BALIS ME; SALSER JS
    Acta Unio Int Contra Cancrum; 1964; 20():115-7. PubMed ID: 14151863
    [No Abstract]   [Full Text] [Related]  

  • 25. [STUDIES ON THE DIFFERENCES IN THE ACTIVITY OF VARIOUS TUMOR-CONTROLLING AGENTS ON ASCITES HEPATOMA CELL LINES].
    SAKURAI Y; TSUKAKOSHI S
    Saishin Igaku; 1965 Apr; 20():996-1000. PubMed ID: 14317194
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of 4-amino-5-imidazolecarboxamide on the synergistic antineoplastic activity of 6-chloropurine and azaserine.
    Sartorelli AC; Booth BA
    Experientia; 1965 Aug; 21(8):457-8. PubMed ID: 5870913
    [No Abstract]   [Full Text] [Related]  

  • 27. INHIBITION OF FORMYLGLYCINAMIDE RIBONUCLEOTIDE SYNTHESIS IN NEOPLASTIC CELLS BY PURINES AND ANALOGS.
    BROCKMAN RW; CHUMLEY S
    Biochim Biophys Acta; 1965 Mar; 95():365-79. PubMed ID: 14342531
    [No Abstract]   [Full Text] [Related]  

  • 28. Metabolic inhibitors and nucleotide turnover. II. Inhibition of uptake of C14-precursors in rat liver and hepatoma slices.
    WERKHEISER WC; VISSER DW
    Cancer Res; 1955 Nov; 15(10):644-9. PubMed ID: 13270249
    [No Abstract]   [Full Text] [Related]  

  • 29. Enzymatic potential for preformed purine metabolism in hepatomas with different growth rates.
    Rhoads AR; Morris HP
    J Natl Cancer Inst; 1977 Sep; 59(3):905-10. PubMed ID: 197248
    [No Abstract]   [Full Text] [Related]  

  • 30. [EXPERIMENTAL STUDIES OF THE ANTINEOPLASTIC ACTIVITY OF A NEW ANTIBIOTIC, DAUNOMYCIN].
    DIMARCO A; GAETANI M; DORIGOTTI L; SOLDATI M; BELLINI O
    Tumori; 1963; 49():203-17. PubMed ID: 14053964
    [No Abstract]   [Full Text] [Related]  

  • 31. Metabolic inhibitors and nucleotide turnover. I. Inhibition of uptake of radiophosphate in rat liver and hepatoma slices.
    WERKHEISER WC; WINZLER RJ; VISSER DW
    Cancer Res; 1955 Nov; 15(10):641-3. PubMed ID: 13270248
    [No Abstract]   [Full Text] [Related]  

  • 32. BIOCHEMISTRY OF CANCER (METABOLIC ASPECTS).
    BROCKMAN RW; ANDERSON EP
    Annu Rev Biochem; 1963; 32():463-512. PubMed ID: 14144487
    [No Abstract]   [Full Text] [Related]  

  • 33. Searches for exploitable biochemical differences between normal and cancer cells. V. Cellular conservation of purines.
    BENNETT LL; SKIPPER HE; SIMPSON L; WHEELER GP; WILCOX WS
    Cancer Res; 1960 Jan; 20():62-81. PubMed ID: 13798947
    [No Abstract]   [Full Text] [Related]  

  • 34. [RECENT TRENDS IN ANTICARCINOGENIC ANTIBIOTICS].
    UMEZAWA H
    Naika; 1964 Jun; 13():1091-6. PubMed ID: 14172451
    [No Abstract]   [Full Text] [Related]  

  • 35. Synthesis of purines and nucleic acids and catabolism of purines by rat liver and hepatomas.
    Wheeler GP; Alexander JA; Morris HP
    Adv Enzyme Regul; 1964; 2():347-69. PubMed ID: 4285961
    [No Abstract]   [Full Text] [Related]  

  • 36. [PRESENT STATE OF ANTINEOPLASTIC CHEMOTHERAPY FROM THE PHARMACOLOGIC POINT OF VIEW].
    NANETTI L; VALLINI R
    Minerva Med; 1963 Nov; 54():3353-5. PubMed ID: 14126380
    [No Abstract]   [Full Text] [Related]  

  • 37. Acinomycin D and purine transport in cultured rat hepatoma cells.
    Dybing E
    Biochem Pharmacol; 1974 Nov; 23(21):3045-51. PubMed ID: 4373009
    [No Abstract]   [Full Text] [Related]  

  • 38. METABOLIC EFFECTS OF 9-BUTYL-6-THIOGUANINE IN VIVO.
    KIMBALL AP; LEPAGE GA
    Cancer Res; 1963 Dec; 23():1792-9. PubMed ID: 14082874
    [No Abstract]   [Full Text] [Related]  

  • 39. HOST-TUMOR-DRUG RELATIONSHIPS IN EXPERIMENTAL CHEMOTHERAPY SYSTEMS WITH ALLOGENEIC AND XENOGENEIC HOST-TUMOR COMBINATIONS.
    TELLER MN; WOLFF R; WAGSHUL SF
    Cancer Res; 1964 Jan; 24():114-9. PubMed ID: 14106153
    [No Abstract]   [Full Text] [Related]  

  • 40. [Incorporation in vitro of DL-leucine-1-C14 into the proteins of the cells of Yoshida's ascites hepatoma and of ascitic sarcoma 180 in presence of various concentrations of albumin].
    Agostini C; Comi P
    Boll Soc Ital Biol Sper; 1969 Jun; 45(11):776-8. PubMed ID: 4321587
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.